About Median
Median is a publicly listed company based in Valbonne (France) founded in 2002 by Fredrik Brag. Medical imaging software and services are provided for clinical trials. Median has raised $5.28 million across 6 funding rounds from investors including Idinvest Partners, Abingworth and NEA. Its chief executive, as recorded, is Fredrik Brag. Median offers products and services including eyonis, iCRO, and Imaging Lab. Its focus areas include HealthTech, Life Sciences Tech, Research & Development and Image Analysis.
Company details
Median was founded in 2002 in Valbonne, France, by Fredrik Brag. Medical imaging software and services are offered for clinical trials in the healthcare sector. Operations focus on SaaS-based Lesion Management Solutions (LMS), which detect, evaluate, and track lesions in CT scans through automatic and semi-automatic processes. Drug development and patient care markets are served. Cancer cells are identified via computer-aided detection technology.
- Headquarters Valbonne, France
- Founders Fredrik Brag
- Stage Public
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Website mediantechnologies.com
- Social LinkedIn X Facebook YouTube
- Legal Name Median Technologies
- Annual Revenue$27.45 M (USD)1.79as on Dec 31, 2025
- Net Profit-$40.03 M (USD)-34.98as on Dec 31, 2025
- EBITDA-$15.36 M (USD)36.18as on Dec 31, 2025
- Total Equity Funding$5.28M (USD)
in 6 rounds
- InvestorsIdinvest Partners
& 7 more
Products & Services of Median
Median offers a comprehensive portfolio of products and services, including eyonis, iCRO, and Imaging Lab.
AI tool for early detection of lung and liver cancer through image analysis.
Provides oncology trial imaging to accelerate cancer treatment development.
Generates AI-powered data for biopharma drug efficacy and patient selection.
Apps and channels of Median
its YouTube channel Median Technologies has 595 subscribers and 30 videos.
Videos from Median
The most watched videos on Median's YouTube channel, Median Technologies (595 subscribers). Click a video to play it here.
More on Median Technologies.
Funding Insights of Median
Median has successfully raised a total of $5.28M across 6 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $5.28M
- Total Rounds 6
- First Round $5.28M
(Nov 2004)
- Investors Count 8
All 6 funding rounds of Median with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug 2025 | Post-IPO | – | – | ||
| Jul 2023 | $12.84M | Post-IPO | – | – | – |
| Mar 2021 | $33.15M | Post-IPO | – | – | – |
| Jul 2015 | $21.97M | Post-IPO | – | – | |
| Aug 2014 | $26.4M | Post-IPO | – | – | |
| Nov 2004 | $5.28M | Series A | – | – |
8 investors in total: 8 institutional.
Investors in Median
Median has secured backing from 8 investors, including venture fund investors. Prominent investors backing the company include Idinvest Partners, Abingworth and NEA.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Early stage venture capital firm investing in US | 1973 | abingworth.com | London, United Kingdom | |
Venture capital investments are offered to startups by NEA. | nea.com | Menlo Park, United States | ||
Venture capital firm | omegafunds.com | Boston, United States | ||
Equity investments are provided to low and middle market companies. | 1997 | idinvest.com | Paris, France | |
US focused VC firm | dfj.com | Menlo Park, United States | ||
Venture capital investments are managed by Auriga Partners in France. | 1998 | aurigapartners.com | Paris, France | |
| invus.com | ||||
| heralduk.com |
Investor details for Median
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Median
11 people are tracked at Median (7 in leadership, 4 in board & advisors).
| Name | Role | Group |
|---|---|---|
Fredrik Brag | Founder & CEO | Leadership |
Chris Nobels | Chief Technology Officer | Leadership |
Jean-Marc Lorenzo | Sales Director - Strategic Investigator Network | Leadership |
Jean-Christophe Montigny | Chief Financial Officer | Leadership |
Thomas Bonnefont | COO & Chief Commercial Officer | Leadership |
Nicolas Dano | Chief Operating Officer & iCRO Business Unit | Leadership |
Cyril Laurent | COO US | Leadership |
Oern Stuge | Director | Board & advisors |
Kapil Dhingra | Director | Board & advisors |
Tim Haines | Director | Board & advisors |
Oran Muduroglu | Executive Chairman | Board & advisors |
Complete people profiles for Median
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of Median
Median is a publicly listed company on the EURONEXT with ticker symbol ALMDT in France, operating in the Health services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date20 May 2011
- Listed onEuronext: ALMDT
- Listed entityMedian Technologies
- Exchange sectorHealth services
- ISINFR0011049824
- Share price4.05 EUR (+1.37% on the day) · 2026-10-14
- Market capitalisation196,041,214.00 EUR
- Volume (last session)27,400
Financials of Median
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | 23.4M EUR | -34.1M EUR | -13.1M EUR |
| 2024 | 22.9M EUR | -25.2M EUR | -20.5M EUR |
| 2023 | 22.2M EUR | -23.0M EUR | -21.8M EUR |
| 2022 | 23.7M EUR | -20.2M EUR | -22.6M EUR |
| 2021 | 20.6M EUR | -19.3M EUR | -10.9M EUR |
Detailed financial statements for Median
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Median
4 dated milestones of Median across 23 years, from founding to its latest funding, stage changes and deals.
- Founded Median is founded.
- Funding First funding round of $5.3M.
- IPO Lists on the stock exchange (IPO).
- Funding Latest funding round, Post-IPO,.
Web traffic of Median
The website of Median (mediantechnologies.com) receives about 7.9K visits a month and ranks #2,575,747 among all websites worldwide, #3,532 in Biotechnology and Pharmaceuticals.
- Monthly visits7.9K
▲ 5.4% vs previous month
- Unique visitors2.9K
per month
- Global rank#2,575,747
among all websites
- Category rank#3,532
Health · Biotechnology and Pharmaceuticals
- Bounce rate39%
- Pages per visit2.4
- Average visit2 min 09 sec
- DevicesDesktop 26% · Mobile 74%
Websites whose visitors overlap most with Median. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| endocyte.com | 100% | View details | |||
pharmaceutiques.com | pharmaceutiques.com | 76% | #5,843,762 | – | |
| managingmyeloma.com | 69% | View details | |||
swog.org | swog.org | 62% | #1,538,879 | – | |
oncologysandiego.com | oncologysandiego.com | 62% | #7,236,540 | – | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 10 similar websites and full traffic analytics for Median
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 10 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Clinical IT & Data Platforms
2 companies that operate in the same segment as Median (Clinical IT & Data Platforms) in France, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
App-based health insurance is offered to individuals and businesses. | 2016 | Paris, Ile de France, France | USD 863.12 M | 1,606 | ||
Work tech company offering meal and gift vouchers for employees | 2016 | Paris, Ile de France, France | USD 328.44 M | USD 69.96 M | 757 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Median
Complete news archive for Median
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Median
Median was founded in 2002 and raised its 1st funding round 2 years after it was founded.
Median is headquartered in Valbonne, France. It is registered at Valbonne, Provence-alpes-cote D'azur, France.
Fredrik Brag is the CEO of Median, as recorded in our data. They have also founded this company.
Median is a funded company, having raised a total of $5.28M across 6 funding rounds to date. The company's 1st funding round was a Series A of $5.28M, raised on Nov 2004.
Annual revenue of Median is $27.45M as on Dec 31, 2025.
Median was founded in 2002 in Valbonne, France, by Fredrik Brag. Medical imaging software and services are offered for clinical trials in the healthcare sector. Operations focus on SaaS-based Lesion Management Solutions (LMS), which detect, evaluate, and track lesions in CT scans through automatic and semi-automatic processes. Drug development and patient care markets are served. Cancer cells are identified via computer-aided detection technology.
Median offers eyonis, iCRO, and Imaging Lab.
Yes, Median is publicly traded on EURONEXT under the ticker symbol ALMDT.
Median has 8 investors. Key investors include Idinvest Partners, Abingworth, NEA, Omega Funds, and DFJ.